129 related articles for article (PubMed ID: 36464269)
1. Perceived cognitive functioning in breast cancer patients treated with chemotherapy compared to matched healthy women: Evidence from a Portuguese study.
Oliveira AF; Torres A; Teixeira RJ; Monteiro S; Pereira A; Santos IM
Int J Nurs Pract; 2023 Jun; 29(3):e13119. PubMed ID: 36464269
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
3. Cognitive functioning in women with breast cancer: psychometric properties of the Arabic version of the Functional Assessment of Cancer Therapy-Cognitive Function Tool.
Hassan M; Barakat Z; Fares Y; Abou-Abbas L
Health Qual Life Outcomes; 2023 Jan; 21(1):9. PubMed ID: 36707834
[TBL] [Abstract][Full Text] [Related]
4. Validation study of the Functional Assessment of Cancer Therapy-Cognitive Function-Version 3 for the Portuguese population.
Oliveira AF; Santos IM; Fernandes S; Bem-Haja P; Torres A
BMC Psychol; 2022 Dec; 10(1):305. PubMed ID: 36517827
[TBL] [Abstract][Full Text] [Related]
5. Effects of chemotherapy and psychosocial distress on perceived cognitive disturbances in Asian breast cancer patients.
Cheung YT; Shwe M; Chui WK; Chay WY; Ang SF; Dent RA; Yap YS; Lo SK; Ng RC; Chan A
Ann Pharmacother; 2012 Dec; 46(12):1645-55. PubMed ID: 23249868
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment experienced by Chinese breast cancer survivors.
Chen D; Mackenzie L; Hossain SZ; Wang JX; Jiang PL; Wang Y; Qin L; Zhen J; Jia J
Sci Rep; 2023 Dec; 13(1):22245. PubMed ID: 38097726
[TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic factors associated with self-reported cognitive deficits in women with breast cancer: the "CAGE-Cog" study.
Hajj A; Khoury R; Hachem R; Awad A; Hallit S; Sacre H; Nasr F; Karak FE; Chahine G; Kattan J; Khabbaz LR
BMC Cancer; 2022 Sep; 22(1):996. PubMed ID: 36123640
[TBL] [Abstract][Full Text] [Related]
8. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
Psychooncology; 2012 May; 21(5):479-87. PubMed ID: 21351188
[TBL] [Abstract][Full Text] [Related]
9. Life after breast cancer: understanding women's health-related quality of life and sexual functioning.
Ganz PA; Rowland JH; Desmond K; Meyerowitz BE; Wyatt GE
J Clin Oncol; 1998 Feb; 16(2):501-14. PubMed ID: 9469334
[TBL] [Abstract][Full Text] [Related]
10. Modifiable correlates of perceived cognitive function in breast cancer survivors up to 10 years after chemotherapy completion.
Henneghan A; Stuifbergen A; Becker H; Kesler S; King E
J Cancer Surviv; 2018 Apr; 12(2):224-233. PubMed ID: 29116555
[TBL] [Abstract][Full Text] [Related]
11. Subjective cognitive functioning and associations with psychological distress in adult brain tumour survivors.
Nicol C; Ownsworth T; Cubis L; Nguyen W; Foote M; Pinkham MB
J Cancer Surviv; 2019 Oct; 13(5):653-662. PubMed ID: 31313128
[TBL] [Abstract][Full Text] [Related]
12. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR
J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304
[TBL] [Abstract][Full Text] [Related]
13. Clinical and genetic factors associated with anxiety and depression in breast cancer patients: a cross-sectional study.
Hajj A; Hachem R; Khoury R; Hallit S; ElJEBBAWI B; Nasr F; El Karak F; Chahine G; Kattan J; Rabbaa Khabbaz L
BMC Cancer; 2021 Jul; 21(1):872. PubMed ID: 34330229
[TBL] [Abstract][Full Text] [Related]
14. Potential factors associated with perceived cognitive impairment in breast cancer survivors.
Myers JS; Wick JA; Klemp J
Support Care Cancer; 2015 Nov; 23(11):3219-28. PubMed ID: 25832894
[TBL] [Abstract][Full Text] [Related]
15. Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms.
Hsu YH; Chen VC; Hsieh CC; Weng YP; Hsu YT; Hsiao HP; Wang WK; Chen HM; Weng JC; Wu SI; Gossop M
Breast Cancer; 2021 Jan; 28(1):236-245. PubMed ID: 33030667
[TBL] [Abstract][Full Text] [Related]
16. Perceived cognitive changes with chemotherapy for breast cancer: A pilot study.
Piacentine LB; Miller JF; Haberlein S; Bloom AS
Appl Nurs Res; 2016 Feb; 29():9-11. PubMed ID: 26856481
[TBL] [Abstract][Full Text] [Related]
17. Cognitive Perception among Post-Chemotherapy, Non-Chemotherapy Breast Cancer Survivors and Non-Cancer.
Syarif H; Waluyo A; Afiyanti Y
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1775-1780. PubMed ID: 34181333
[TBL] [Abstract][Full Text] [Related]
18. [A Structural Model for Chemotherapy Related Cognitive Impairment and Quality of Life in Breast Cancer Patients].
Lee JR; Oh PJ
J Korean Acad Nurs; 2019 Aug; 49(4):375-385. PubMed ID: 31477668
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy and cognitive complaints in women with breast cancer.
Pullens MJ; De Vries J; Van Warmerdam LJ; Van De Wal MA; Roukema JA
Psychooncology; 2013 Aug; 22(8):1783-9. PubMed ID: 23109296
[TBL] [Abstract][Full Text] [Related]
20. The role of depression in the relationship between cognitive decline and quality of life among breast cancer patients.
Park JH; Jung YS; Jung YM; Bae SH
Support Care Cancer; 2019 Jul; 27(7):2707-2714. PubMed ID: 30498990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
